Salicylic Acid

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, 'cauliflower-like' surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting tenderness and disrupting the normal footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

After washing the affected area, the wart should be soaked in comfortably warm water for 5 minutes. Following this, the area must be dried thoroughly. One drop of gel should be applied at a time to ensure sufficient coverage of each wart. The gel should be allowed to dry completely.

This procedure should be repeated once or twice daily until the wart is removed, with a maximum treatment duration of up to 12 weeks.

Contraindications

Use is contraindicated in the following situations:

• Application on moles, birthmarks, and warts with hair growing from them is prohibited due to the potential for adverse effects.

• The product should not be applied to mucous membranes, including the nose, anus, genitals, and lips, to avoid irritation and complications.

• Use is contraindicated on irritated, infected, or reddened skin, as this may exacerbate the condition.

• The application is not recommended for genital warts and warts located on the face due to the sensitive nature of these areas.

• Patients with diabetes or poor blood circulation should not use this product unless under the advice and supervision of a healthcare professional, as these conditions may increase the risk of complications.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from fire and flame to prevent any risk of ignition.

General precautions should be observed to ensure safe use. The product must not be applied to moles, birthmarks, or warts that have hair growing from them. It is contraindicated for use on mucous membranes, including the nose, anus, genitals, and lips. Additionally, the product should not be used on irritated, infected, or reddened skin, nor should it be applied to genital warts or warts located on the face. Individuals with diabetes or poor blood circulation should avoid using this product unless under the advice and supervision of a qualified healthcare professional, such as a doctor or podiatrist.

In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

If discomfort persists after application, it is essential to discontinue use and consult a healthcare provider, such as a doctor or podiatrist, for further evaluation and management.

Side Effects

Patients should be aware that this product is for external use only and is flammable; it should be kept away from fire and flame. The product should not be used on moles, birthmarks, or warts with hair growing from them, nor should it be applied to mucous membranes such as the nose, anus, genitals, and lips. Additionally, it is contraindicated for use on irritated, infected, or reddened skin, as well as on genital warts and warts on the face. Patients who are diabetic or have poor blood circulation should only use this product under the advice and supervision of a doctor or podiatrist.

During the use of this product, if it comes into contact with the eyes, it is important to flush the eyes with water for 15 minutes. Patients should also avoid inhaling vapors associated with the product.

This product should be kept out of reach of children. In the event of accidental ingestion, medical help should be sought immediately, or contact with a Poison Control Center should be made. If discomfort persists after use, patients are advised to consult their doctor or podiatrist.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Salicylic Acid (wart remover gel). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as they may have altered pharmacokinetics and pharmacodynamics. Close monitoring is recommended to ensure safety and efficacy in this population.

Pregnancy

Pregnant patients may use this medication as no explicit safety concerns regarding pregnancy have been stated. There are no dosage modifications recommended for pregnant individuals, nor are there any special precautions regarding its use during pregnancy. Healthcare professionals should continue to monitor the latest research and guidelines to ensure the safety and well-being of both the patient and the fetus.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants during the use of this product.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment and monitoring of the patient are essential.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous evaluation and appropriate interventions should be implemented as necessary to ensure patient safety and recovery.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. In the event of swallowing the product, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be informed that this product is not intended for use on moles, birthmarks, or warts with hair growing from them. Additionally, it should not be applied to mucous membranes, including the nose, anus, genitals, and lips. Healthcare providers should emphasize that the product should not be used on irritated, infected, or reddened skin, nor on genital warts or warts located on the face.

It is crucial to inform patients that individuals who are diabetic or have poor blood circulation should not use this product unless under the advice and supervision of a healthcare professional, such as a doctor or podiatrist.

Patients should be instructed to flush their eyes with water for 15 minutes if the product accidentally gets into their eyes. Furthermore, they should avoid inhaling vapors while using the product. If discomfort persists after application, patients are encouraged to consult their doctor or podiatrist for further evaluation and guidance.

Storage and Handling

The product is supplied in configurations that adhere to the specified NDC numbers. It is essential to store the product in a controlled environment, maintaining a temperature range between 59°F to 86°F (15°C to 30°C).

Care should be taken to keep the product away from fire and flame to ensure safety and integrity. Proper storage conditions are crucial for maintaining the quality and efficacy of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Salicylic Acid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)